ETRA

Healthcare Biotechnology

Electra Therapeutics, Inc.

$9.82

+0.08 +0.82% today

Price History

Not enough data

Key Stats

Market Cap

616.37M

Avg Volume

1.05M

EPS

-$2.65

52W High

$15.50

52W Low

$9.28

Div. Yield

0.0%

Valuation

P/B Ratio

-0.00

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Liquidity & Leverage

Current Ratio

7.37

Quick Ratio

7.19

Debt / Equity

0.02

Total Cash

97.72M

Total Debt

1.98M

About

Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel targets for diseases in immunology and cancer. Its product, ELA026, is a monoclonal antibody that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, enabling medical professionals to find an approved treatment for secondary hemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory condition. The company was incorporated in 2018 and is based in South San Francisco, California.

electra-therapeutics.com